Introduction to pharmacology

Osmosis from Elsevier
27 Feb 202407:47

Summary

TLDRThis script explores the complex journey of drug development, from discovery to clinical trials, emphasizing the importance of safety, efficacy, and therapeutic index. It delves into pharmacokinetics and pharmacodynamics, highlighting how medications interact with the body and the potential for drug interactions, crucial for clinicians to understand.

Takeaways

  • 💊 Pharmacology is the study of how medications interact with living systems, from molecules to whole organisms, to produce effects.
  • 🔍 Developing a new medication involves three main steps: Discovery, Pre-clinical research, and Clinical development.
  • 🔬 Discovery is when a potential therapeutic compound is identified for a specific disease.
  • 🐁 Pre-clinical research tests the compound on cell cultures and animals to assess safety.
  • 🏥 Clinical development includes clinical trials on humans, conducted in four phases to evaluate safety, efficacy, and real-life application.
  • 🧪 Phase 1 trials assess safety in a small group of healthy individuals.
  • 🔍 Phase 2 trials determine the medication's effectiveness in a moderate group of affected individuals.
  • 🏥 Phase 3 trials compare the new medication to standard treatment in a larger group to evaluate superiority or equivalence.
  • 🏛️ Regulatory approval is based on the results of Phase 3 trials, which simulate real-life medication administration.
  • 💡 A new medication can have three names: a chemical name, a generic name, and one or more brand names.
  • 🌐 After approval, Phase 4 involves post-market surveillance for long-term or rare side effects.
  • 💉 Pharmacokinetics studies how the body processes a medication (absorption, distribution, metabolism, and excretion).
  • 🔬 Pharmacodynamics studies the effects a medication has on the body, including both therapeutic and side effects.
  • 🚑 Medications with a low therapeutic index have a narrow margin of safety and require close monitoring.
  • 🤝 Drug interactions can occur at both pharmacokinetic and pharmacodynamic levels, affecting how medications are absorbed, metabolized, and interact with each other.

Q & A

  • What is pharmacology?

    -Pharmacology is the study of medications or chemical compounds that interact with living systems, from molecules to whole organisms, to produce a certain effect. It involves understanding how these substances are used to treat diseases.

  • What are the three main steps in the development of a new medication?

    -The three main steps in the development of a new medication are discovery, pre-clinical research, and clinical development. Discovery involves identifying a potential therapeutic compound, pre-clinical research tests the compound on cell cultures and animals, and clinical development includes clinical trials on humans.

  • What is the purpose of pre-clinical research in drug development?

    -Pre-clinical research is conducted to test the candidate compound on cell cultures and animals, primarily to determine if it causes any serious harm to living organisms. This step is crucial for understanding the safety profile of the compound before it is tested on humans.

  • What are the four phases of clinical trials for a new medication?

    -The four phases of clinical trials are: Phase 1, which tests the medication in a small group of healthy individuals for safety; Phase 2, which assesses the medication's effectiveness and optimal dosage in a moderately sized group of affected individuals; Phase 3, which compares the new medication to standard treatment in a larger group to determine its efficacy; and Phase 4, which is a post-marketing surveillance phase to monitor long-term safety and detect rare side effects.

  • What does the acronym 'SEAL' stand for in the context of clinical trials?

    -In the context of clinical trials, 'SEAL' stands for Safety, Efficacy, Approval, and Long-term phase, which are the key aspects that need to be addressed to ensure a medication is safe and effective for use.

  • Why are there three names for a medication?

    -A medication has three names to describe different aspects of its identity: a chemical name that describes its chemical structure (e.g., N-Acetal P Amino phenol), a generic name that is a shortened version used by health professionals (e.g., paracetamol or acetaminophen), and one or more brand or trade names given by pharmaceutical companies (e.g., Panadol or Tylenol).

  • What is pharmacokinetics and what does it involve?

    -Pharmacokinetics refers to the movement and modification of a medication within the body. It involves the absorption of the medication into the circulation, its distribution to various tissues, metabolism or breakdown, and finally, its elimination from the body, typically through urine or feces.

  • What is pharmacodynamics and how does it differ from pharmacokinetics?

    -Pharmacodynamics refers to the effects that a medication has on the body. It involves how the medication interacts with receptors or proteins in the body, leading to changes in cellular function. This is different from pharmacokinetics, which focuses on how the body processes the medication.

  • What is the therapeutic index and why is it important?

    -The therapeutic index is the ratio between the toxic dose (TD50) and the effective dose (ED50) of a medication. It indicates the safety margin of a drug, with a larger index indicating a safer medication. Medications with a low therapeutic index require close monitoring to prevent toxicity.

  • How can medications interact with each other, and what are the potential effects?

    -Medications can interact with each other at both pharmacokinetic and pharmacodynamic levels. Pharmacokinetic interactions occur when one medication alters the absorption, distribution, metabolism, or excretion of another. Pharmacodynamic interactions occur when medications directly influence each other's effects, potentially leading to synergistic or antagonistic effects.

Outlines

00:00

💊 Understanding Medication Development and Interaction

This paragraph delves into the intricate world of pharmacology, focusing on the development of new medications. It outlines the three main steps involved: Discovery, where a potential therapeutic compound is identified; Pre-clinical research, involving testing on cell cultures and animals to assess safety; and Clinical development, encompassing clinical trials in four phases to evaluate safety and efficacy. The paragraph also touches on the naming conventions for medications, including chemical, generic, and brand names. Additionally, it highlights the importance of pharmacokinetics and pharmacodynamics in understanding how medications interact with the body, and the concept of the therapeutic index, which measures the safety of a medication by comparing its toxic and effective doses.

05:02

🔍 Exploring Drug Interactions and Safety Margins

The second paragraph expands on the complexities of drug interactions and the safety considerations in medication use. It discusses the therapeutic index, emphasizing its role in determining the safety of a drug by comparing the median toxic dose to the median effective dose. Medications with a low therapeutic index are highlighted as needing close monitoring due to their narrow margin of safety. The paragraph also explores pharmacokinetic and pharmacodynamic interactions, explaining how drugs can influence each other's effects, either through competition for metabolic enzymes or by directly affecting each other's actions. The potential for synergistic or antagonistic effects between medications is also discussed, illustrating the importance of understanding these interactions to ensure safe and effective treatment.

Mindmap

Keywords

💡Pharmacology

Pharmacology is the scientific study of drugs and their interactions with living systems. It encompasses understanding how drugs work at the molecular, cellular, and organism level. In the video, pharmacology is central to the discussion of how medications are developed and interact with the body, from discovery to clinical trials and beyond.

💡Medications

Medications are chemical compounds designed to treat diseases or conditions. The video script discusses the development process of new medications, highlighting the stages from discovery to clinical trials, and their importance in treating various diseases such as infections, cancer, heart failure, and depression.

💡Discovery

In the context of drug development, discovery refers to the initial phase where a potential therapeutic compound is identified. The script mentions this as the first step in developing a new medication, where a candidate compound is selected for its potential to treat a specific disease.

💡Pre-clinical research

Pre-clinical research is the stage in drug development where a compound is tested on cell cultures and animals to assess its safety and potential harm. The script explains that this phase is crucial for determining whether the compound can proceed to clinical trials involving humans.

💡Clinical trials

Clinical trials are experiments conducted on humans to determine the safety and effectiveness of a medication. The video script details the four phases of clinical trials, emphasizing their role in the approval process for new medications and their importance in ensuring the drug's efficacy and safety.

💡Pharmacokinetics

Pharmacokinetics is the study of how the body processes a drug, including its absorption, distribution, metabolism, and excretion (ADME). The script uses the term to describe the movement and modification of a medication within the body, which is critical for understanding how a drug behaves once administered.

💡Pharmacodynamics

Pharmacodynamics refers to the study of the effects a drug has on the body, including its mechanism of action and the resulting physiological changes. The script explains how this relates to how a medication interacts with receptors and proteins in the body, leading to therapeutic or side effects.

💡Therapeutic index

The therapeutic index is a measure of a drug's safety, calculated as the ratio between the toxic dose and the effective dose. The video script uses this concept to illustrate how medications with a narrow therapeutic index require close monitoring to prevent toxicity, as there is a small margin between the effective and toxic doses.

💡Generic name

A generic name is the non-proprietary name given to a medication, often a shortened version of its chemical name. The script mentions that generic names are used by health professionals and are distinct from brand names, which are given by pharmaceutical companies.

💡Brand name

A brand name is the proprietary name given to a medication by the company that manufactures it. The video script provides examples such as Panadol or Tylenol, which are brand names for the generic drug acetaminophen.

💡Drug interactions

Drug interactions occur when two or more medications affect each other's actions, either by altering their pharmacokinetics or pharmacodynamics. The script discusses how these interactions can be synergistic (enhancing effects) or antagonistic (opposing effects), and the importance of understanding these interactions for safe medication use.

Highlights

Pharmacology is the study of medications and their interactions with living systems.

New medications are designed to fight diseases such as infections, cancer, heart failure, and depression.

Developing a new medication is a lengthy and costly process.

The drug development process consists of three main steps: Discovery, Pre-clinical research, and Clinical development.

Discovery involves selecting a candidate compound as a potential therapeutic agent.

Pre-clinical research tests the compound on cell cultures and animals to assess safety.

Clinical development involves testing the compound on humans through clinical trials.

Clinical trials are conducted in four phases, each with a specific purpose.

Phase one trials test the medication's safety in a small group of healthy individuals.

Phase two trials determine the medication's effectiveness and optimal dosage.

Phase three trials compare the new medication to standard treatment to assess its efficacy.

Phase four is a post-market surveillance phase that monitors for long-term or rare side effects.

A new medication will have a chemical name, a generic name, and one or more brand names.

Drug administration involves pharmacokinetics, which studies the movement and modification of the medication in the body.

Pharmacodynamics studies the effects of the medication on the body, including beneficial and side effects.

The therapeutic index measures the safety of a medication by comparing the toxic dose to the effective dose.

Medications with a low therapeutic index require close monitoring to prevent toxicity.

Drug interactions can occur at both pharmacokinetic and pharmacodynamic levels.

Pharmacokinetic interactions involve one medication altering the absorption, distribution, metabolism, or excretion of another.

Pharmacodynamic interactions occur when medications directly influence each other's effects.

Transcripts

play00:03

pharmacology is the study of medications

play00:05

or chemical compounds which interact

play00:08

with various living systems from Tiny

play00:10

molecules to cells to tissues and whole

play00:12

organisms in order to produce a certain

play00:16

effect every day more and more new

play00:19

medications are designed to fight

play00:21

diseases from infections to cancer heart

play00:24

failure and depression but the process

play00:26

of developing a new medication can take

play00:28

a lot of time and money and it typically

play00:30

consists of Three Steps step one is

play00:33

Discovery and that's when a candidate

play00:35

compound is picked out as a possible

play00:37

therapeutic agent for a specific disease

play00:40

step two is pre-clinical research during

play00:42

which this compound is tested on Cell

play00:44

cultures and animals like mice and rats

play00:47

mainly to see if it causes any serious

play00:49

harm on living organisms and finally

play00:52

step three is clinical development

play00:54

during which clinical trials are

play00:56

performed that's where the compound is

play00:58

tested on humans to see if if it's safe

play01:00

and effective in treating

play01:03

diseases for a new medication clinical

play01:05

trials are done in four phases which can

play01:07

be remembered with the pneumonic all

play01:09

medications need the seal of approval

play01:12

which stands for safety efficacy

play01:14

approval and longterm phase one trials

play01:17

test the medication in a small group of

play01:19

healthy individuals to see if it's safe

play01:22

for

play01:25

humans Phase 2 trials aim to find out

play01:27

more about how effective the medication

play01:30

is or how well it works at a certain

play01:32

dose this is done by testing it on a

play01:34

moderately sized group of individuals

play01:36

affected by the condition in

play01:39

question in phase three trials the new

play01:42

medication is compared to the standard

play01:44

treatment to find out if it's actually

play01:46

just as good as or even better than the

play01:48

existing one phase 3 trials generally

play01:51

involve a much larger number of

play01:53

individuals and aim to replicate the

play01:55

exact setting in which the medication

play01:57

will be administered in real life which

play01:59

will then be used used as the basis for

play02:00

approval by regulatory organizations for

play02:03

the

play02:06

market the whole process can take up to

play02:08

10 years or more depending on the

play02:10

compound but if all this goes well

play02:12

congratulations we've got a new

play02:17

medication now that new medication will

play02:19

have at least three names a chemical one

play02:22

describing its chemical structure and

play02:24

used mostly in scientific studies like n

play02:26

acetal P Amino phenol a generic name

play02:29

which which is usually a shortened

play02:30

version of the chemical name and is

play02:32

mostly used by health professionals such

play02:34

as paracetamol or acetaminophen and one

play02:37

or more brand or trade names given by

play02:39

the pharmaceutical companies that make

play02:41

the medication such as Panadol or

play02:45

Tylenol okay but the Journey of drug

play02:47

development hasn't finished quite yet

play02:50

once a medication reaches the

play02:51

marketplace there's phase four which is

play02:53

a final phase of safety surveillance

play02:55

that looks for long-term or rare side

play02:57

effects that might have been missed if

play02:59

it's found to be unsafe a recall and ban

play03:02

might be

play03:04

needed all right now once a medication

play03:07

is administered it starts interacting

play03:09

with the body this interaction can be

play03:11

broken down into pharmacokinetics and

play03:16

pharmacodynamics pharmacokinetics refers

play03:19

to the movement and modification of the

play03:21

medication inside the body in other

play03:23

words it's what the body does to this

play03:25

medication so once the medication gets

play03:28

administered it first has to absorbed

play03:30

into the circulation then distributed to

play03:32

various tissues throughout the body

play03:34

metabolized or broken down and finally

play03:37

eliminated or excreted in the urine or

play03:39

feces you can remember this as adme

play03:42

absorption distribution metabolism and

play03:48

excretion pharmacodynamics on the other

play03:51

hand refers to what the medication does

play03:53

to the body so once again after the

play03:55

administration of a medication it binds

play03:57

to receptors or specialized proteins

play04:00

located on the surface of or inside a

play04:02

cell this gives rise to a signal Cascade

play04:05

which ultimately results in some change

play04:07

in the cell's function like boosting the

play04:10

production of a particular type of

play04:11

protein or slowing down DNA replication

play04:14

an ideal medication would produce a

play04:16

single beneficial or therapeutic effect

play04:19

for a certain disease state in reality

play04:21

though most medications produce several

play04:23

unwanted effects called side effects

play04:26

like nausea or

play04:27

fatigue now in order to deter the safety

play04:30

of a medication we can look at its

play04:32

therapeutic index the therapeutic index

play04:35

refers to the ratio between the toxic

play04:37

dose and effective dose of a given

play04:39

medication we can illustrate this using

play04:41

a nice graph that shows the relationship

play04:43

between the amount of a medication given

play04:45

also known as dose on the x-axis usually

play04:49

on a logarithmic scale with the response

play04:51

produced on the y- AIS what we get is an

play04:54

s-shaped curve called dose response

play04:56

curve so to calculate the therapeutic

play04:59

index we divide the median toxic dose or

play05:02

td50 which is the dose that causes a

play05:04

toxic response in 50% of the population

play05:07

by the median effective dose or ed50

play05:10

which is the dose that produces a

play05:11

clinically desired effect in 50% of the

play05:14

population the closer the ratio is to

play05:16

one the higher the danger of toxicity so

play05:19

the larger the therapeutic index the

play05:21

safer a medication is considered to

play05:25

be all right medications that have a low

play05:28

therapeutic index have a narrow margin

play05:30

of safety which means that there is a

play05:32

thin line between the dose needed to

play05:34

produce the desired effect and the toxic

play05:36

dose so these medications including

play05:39

warin lithium dexin gentamycin phenin or

play05:43

theophine require close monitoring of

play05:46

serum

play05:49

levels finally let's talk about what

play05:52

happens when two or more medications are

play05:54

administered together first of all there

play05:56

are a whole bunch of ways medications

play05:58

can interact with each other both at

play06:00

pharmacokinetic and pharmacodynamic

play06:02

levels pharmacokinetic interactions

play06:05

occur when one medication Alters the

play06:07

absorption distribution metabolism or

play06:09

excretion of another thereby changing

play06:12

the amount of medication available to

play06:14

produce the desired effect for example

play06:16

in pharmacokinetics it might be that two

play06:19

medications are metabolized by the same

play06:21

enzymes so they compete for the same

play06:23

enzyme sites on the other hand

play06:26

pharmacodynamic interactions occur when

play06:28

medications influen each other's effects

play06:30

directly for example two medications

play06:33

might both increase the blood pressure

play06:35

producing a synergistic effect where the

play06:37

blood pressure goes up even higher than

play06:39

what you'd expect by simply adding the

play06:41

two medication effects together likewise

play06:44

a medication might work to increase

play06:45

blood pressure by simply opposing the

play06:47

effect of another medication thereby

play06:49

having an antagonistic

play06:53

effect all right as a quick recap each

play06:57

medication is developed in three steps a

play06:59

discovery preclinical and clinical step

play07:02

and has three names a chemical generic

play07:05

and brand name pharmacokinetics studies

play07:08

what the body does to a medication and

play07:10

pharmacodynamics studies what a

play07:12

medication does to the body including

play07:14

its beneficial and side effects

play07:16

medications with a narrow therapeutic

play07:18

index need to be closely monitored to

play07:20

prevent toxicity drug interactions may

play07:23

occur on both pharmacokinetic and

play07:25

pharmacodynamic

play07:28

levels

play07:32

helping current and future clinicians

play07:34

Focus learn retain and Thrive learn

play07:45

more

Rate This

5.0 / 5 (0 votes)

Связанные теги
PharmacologyDrug DevelopmentClinical TrialsMedicationsTherapeutic IndexPharmacokineticsPharmacodynamicsSafety SurveillanceDrug InteractionsHealth Professionals
Вам нужно краткое изложение на английском?